Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kemin Capsule for post-infectious cough (yang deficiency, wind-cold obstructing lung)
CTR20230863Phase 2Completed
- Sponsor
- Jinan Kangzhong Pharmaceutical Technology Development
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in postinfectious cough, sponsored by Jinan Kangzhong Pharmaceutical Technology Development. Started Mar 2023; status: completed.
02
Drugs
clemastine
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on CTR20230863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230863.